These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 38641945)

  • 1. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma.
    Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
    Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers related with seizure risk in glioma patients: A systematic review.
    Zhou XW; Wang X; Yang Y; Luo JW; Dong H; Liu YH; Mao Q
    Clin Neurol Neurosurg; 2016 Dec; 151():113-119. PubMed ID: 27821299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy in Patients with Gliomas.
    Ehara T; Ohka F; Motomura K; Saito R
    Neurol Med Chir (Tokyo); 2024 Jul; 64(7):253-260. PubMed ID: 38839295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of miR-196b in tumor-related epilepsy of patients with gliomas.
    You G; Yan W; Zhang W; Wang Y; Bao Z; Li S; Li S; Li G; Song Y; Kang C; Jiang T
    PLoS One; 2012; 7(9):e46218. PubMed ID: 23049982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
    Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
    J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO4 expression is associated with the occurrence and outcome of seizures: An RNA-sequencing analysis of low-grade gliomas.
    Wang Y; Tang K; Zhao J; Liu L; Feng J
    Seizure; 2017 Nov; 52():41-45. PubMed ID: 28963932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
    Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
    Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of BRAF V600E Gene Mutation in Patients of Epilepsy-Associated Brain Tumor: a Meta-analysis.
    Xing H; Song Y; Zhang Z; Koch PD
    J Mol Neurosci; 2021 Sep; 71(9):1815-1824. PubMed ID: 33791912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics integration and epilepsy: Towards a better understanding of biological mechanisms.
    Chong D; Jones NC; Schittenhelm RB; Anderson A; Casillas-Espinosa PM
    Prog Neurobiol; 2023 Aug; 227():102480. PubMed ID: 37286031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
    Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
    Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of epilepsy in brain tumor patients.
    van der Meer PB; Taphoorn MJB; Koekkoek JAF
    Curr Opin Oncol; 2022 Nov; 34(6):685-690. PubMed ID: 35838207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF V600E mutation in epilepsy-associated glioneuronal tumors: Prevalence and correlation with clinical features in a Chinese population.
    Zhang YX; Shen CH; Guo Y; Zheng Y; Zhu JM; Ding Y; Tang YL; Wang S; Ding MP
    Seizure; 2017 Feb; 45():102-106. PubMed ID: 27984807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy in patients with gliomas: incidence and control of seizures.
    Iuchi T; Hasegawa Y; Kawasaki K; Sakaida T
    J Clin Neurosci; 2015 Jan; 22(1):87-91. PubMed ID: 25192590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.
    Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M
    Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
    Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
    J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2A1 is a potential biomarker for postoperative seizure control in patients with low-grade gliomas.
    You G; Feng L; Yan W; Zhang W; Wang YZ; Li SW; Li SW; Li GL; Song YJ; Kang CS; You YP; Jiang T
    CNS Neurosci Ther; 2013 Nov; 19(11):882-8. PubMed ID: 23841872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gliomas and seizures.
    Prakash O; Lukiw WJ; Peruzzi F; Reiss K; Musto AE
    Med Hypotheses; 2012 Nov; 79(5):622-6. PubMed ID: 22959996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.